These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31559869)

  • 41. The preferences of women in Australia for the features of long-acting reversible contraception: results of a discrete choice experiment.
    Haas M; Church J; Street DJ; Bateson D; Fisher J; Taft A; Black KI; Lucke J; Hussainy SY; McGeechan K; Norman W; Mazza D
    Eur J Contracept Reprod Health Care; 2022 Oct; 27(5):424-430. PubMed ID: 35899828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of Long-Acting Reversible Contraception by Obstetrics and Gynecology Residents: An Examination of Access for All Women.
    Evans ML; Espey E; Ogburn T; Zite NB
    Obstet Gynecol; 2018 Mar; 131(3):538-541. PubMed ID: 29420403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trends in long-acting reversible contraceptive (LARC) use, LARC use predictors, and dual-method use among a national sample of college women.
    Walsh-Buhi ER; Helmy HL
    J Am Coll Health; 2018; 66(4):225-236. PubMed ID: 29111911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attitudes, awareness, compliance and preferences among hormonal contraception users: a global, cross-sectional, self-administered, online survey.
    Hooper DJ
    Clin Drug Investig; 2010; 30(11):749-63. PubMed ID: 20818837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
    Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
    Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraception.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Contraception; 2015 Mar; 91(3):185-92. PubMed ID: 25500324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Profile of long-acting reversible contraception users in Europe.
    Haimovich S
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):187-95. PubMed ID: 19565416
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-acting reversible contraceptives for adolescent females: a review of current best practices.
    Sherin M; Waters J
    Curr Opin Pediatr; 2019 Oct; 31(5):675-682. PubMed ID: 31361677
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are there unmet needs in contraceptive counselling and choice? Findings of the European TANCO Study.
    Merki-Feld GS; Caetano C; Porz TC; Bitzer J
    Eur J Contracept Reprod Health Care; 2018 Jun; 23(3):183-193. PubMed ID: 29785864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-acting reversible contraception.
    Peck SA
    Nurs Womens Health; 2013 Oct; 17(5):431-5. PubMed ID: 24138662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-acting reversible contraceptive use in the post-abortion period among women seeking abortion in mainland China: intentions and barriers.
    Luo Z; Gao L; Anguzu R; Zhao J
    Reprod Health; 2018 May; 15(1):85. PubMed ID: 29793501
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-acting reversible contraception in adolescents in Sub-Saharan Africa: evidence from demographic and health surveys.
    McCurdy RJ; Jiang X; Schnatz PF
    Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):357-364. PubMed ID: 30465692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Availability of long-acting reversible contraceptives in Los Angeles County clinics through a Medicaid state plan amendment program.
    Natavio M; Blotky E; Van Horn CM; Waters C; Ihenacho U; Silverstein E; Cortessis VK; Nelson AL
    Contraception; 2018 Dec; 98(6):471-475. PubMed ID: 30076832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.
    Rafie S; McIntosh J; Shealy KM; Borgelt LM; Forinash A; Shrader SP; Koepf ER; McClendon KS; Griffin BL; Horlen C; Karaoui LR; Rowe EL; Lodise NM; Wigle PR
    Pharmacotherapy; 2014 Sep; 34(9):991-9. PubMed ID: 24989020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors influencing use of long-acting versus short-acting contraceptive methods among reproductive-age women in a resource-limited setting.
    Tibaijuka L; Odongo R; Welikhe E; Mukisa W; Kugonza L; Busingye I; Nabukalu P; Ngonzi J; Asiimwe SB; Bajunirwe F
    BMC Womens Health; 2017 Apr; 17(1):25. PubMed ID: 28376779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 'But you can't reverse a hysterectomy!' Perceptions of long acting reversible contraception (LARC) among young women aged 16-24 years: a qualitative study.
    Okpo E; Allerton L; Brechin S
    Public Health; 2014 Oct; 128(10):934-9. PubMed ID: 25369357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is Long-Acting Reversible Contraceptive Use Increasing? Assessing Trends Among U.S. College Women, 2008-2013.
    Logan RG; Thompson EL; Vamos CA; Griner SB; Vázquez-Otero C; Daley EM
    Matern Child Health J; 2018 Nov; 22(11):1639-1646. PubMed ID: 29936659
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Awareness and Use of Contraceptive Methods and Perceptions of Long-Acting Reversible Contraception Among White and Non-White Women.
    Lin CJ; Maier J; Nwankwo C; Burley C; deBorja L; Aaraj YA; Lewis E; Rhem M; Nowalk MP; South-Paul J
    J Womens Health (Larchmt); 2021 Sep; 30(9):1313-1320. PubMed ID: 33297819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.